These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20049592)

  • 21. Injectable calcium hydroxylapatite microspheres (Radiesse).
    Ridenour B; Kontis TC
    Facial Plast Surg; 2009 May; 25(2):100-5. PubMed ID: 19415577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
    Lizzul PF; Narurkar VA
    J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects when injecting facial fillers.
    Gladstone HB; Cohen JL
    Semin Cutan Med Surg; 2007 Mar; 26(1):34-9. PubMed ID: 17349561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report of ophthalmic artery emboli secondary to Calcium Hydroxylapatite filler injection for nose augmentation- long-term outcome.
    Cohen E; Yatziv Y; Leibovitch I; Kesler A; Cnaan RB; Klein A; Goldenberg D; Habot-Wilner Z
    BMC Ophthalmol; 2016 Jul; 16():98. PubMed ID: 27391691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium hydroxylapatite: A review on safety and complications.
    Kadouch JA
    J Cosmet Dermatol; 2017 Jun; 16(2):152-161. PubMed ID: 28247924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperdiluted Calcium Hydroxylapatite 1: 2 for Mid and Lower Facial Skin Rejuvenation: Efficacy and Safety.
    Rovatti PP; Pellacani G; Guida S
    Dermatol Surg; 2020 Dec; 46(12):e112-e117. PubMed ID: 32205749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular Complications Following Cosmetic Filler Injection.
    Sung WI; Tsai S; Chen LJ
    JAMA Ophthalmol; 2018 May; 136(5):e180716. PubMed ID: 29800254
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute isolated trigeminal neuropathy following calcium hydroxylapatite-based soft tissue filler injection: A case report.
    Mingazova L; Karpova E; Murakov S; Orlova O; Golubev V; Cotofana S
    J Cosmet Dermatol; 2021 May; 20(5):1505-1511. PubMed ID: 33547864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soft tissue calcifications in the lower extremities of severely diabetic patients simulating venous stasis or collagen vascular disease.
    Gaughen JR; Keats TE
    Emerg Radiol; 2006 Dec; 13(3):135-8. PubMed ID: 17031608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral calcifications secondary to synthetic soft tissue augmentation of the cheeks: report of a case.
    Mupparapu M; Mozaffari E
    Dentomaxillofac Radiol; 2002 Nov; 31(6):388-90. PubMed ID: 12424639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral and maxillofacial pathology case of the month. Foreign body giant cell reaction to cosmetic filler material Radiesse.
    Assi ; Pope ; Kessler
    Tex Dent J; 2013 Jul; 130(7):582, 620-1. PubMed ID: 24015449
    [No Abstract]   [Full Text] [Related]  

  • 33. Light Perception Vision Recovery After Treatment for Calcium Hydroxylapatite Cosmetic Filler-Induced Blindness.
    Vu PQ; Grob SR; Tao JP
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):e189-e192. PubMed ID: 30234833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in Nasal Sensibility Following Calcium Hydroxyapatite Dorsal Augmentation.
    Alharethy S
    J Craniofac Surg; 2018 Mar; 29(2):e104-e106. PubMed ID: 29068971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management.
    Beer KR
    J Drugs Dermatol; 2007 Aug; 6(8):846-7. PubMed ID: 17763619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
    Sadick NS; Katz BE; Roy D
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of soft tissue augmentation.
    Hirsch RJ; Stier M
    J Drugs Dermatol; 2008 Sep; 7(9):841-5. PubMed ID: 19112797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide.
    Htet TD; Eisman JA; Elder GJ; Center JR
    Osteoporos Int; 2018 Feb; 29(2):517-518. PubMed ID: 29247298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium hydroxylapatite for facial rejuvenation.
    Berlin A; Cohen JL; Goldberg DJ
    Semin Cutan Med Surg; 2006 Sep; 25(3):132-7. PubMed ID: 17055392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.